| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Adaptive Spectrum and Signal Alignment, Inc. (ASSIA®) is a strategic partner and trusted solutions vendor to broadband service providers worldwide. ASSIA`s market leading solutions enable providers to grow revenues, increase customer satisfaction, improve operational efficiencies, and deliver new multimedia content to the broadband and Wi-Fi enabled home. With more than 100 million broadband and Wi-Fi lines under contract with top-tier service providers worldwide, ASSIA products and services deliver the performance and reliability needed to support the ever increasing demand on broadband and Wi-Fi in the home. ASSIA was founded in 2003 by Dr. John Cioffi, renowned expert in DSL technology and professor emeritus of electrical engineering at Stanford University. The company was created to help service providers realize breakthrough improvements in the performance and profitability of their DSL networks. Later ASSIA`s vision recognized the need for similar improvements with the popularity of Wi-Fi in the home leveraging many of the company`s market leading diagnostic and optimization technology and expertise. The company is financially solid/profitable and grew over 50% in 2017 by expanding its customer base and through new product sales to existing customers. All four key product lines including CloudCheck®, ClearView®, DSL Expresse® and GPON Expresse® are growing. The company is backed by strategic investors including AT&T, Mingly China Growth Fund, SFR Development, Sandalwood Partners, Sofinnova Ventures, Stanford University, Swisscom Ventures, Telefónica, T-Ventures and ValueGate.
Revolutionizing Healing. Changing Lives. The power of nanofiber technology.
Zoxsoft is a Los Angeles, CA-based company in the Software and Internet sector.